Search for Clinical Trial Results

Sponsored By

Large Granular Lymphocyte Leukemia - 3 Studies Found

Status Study
Active, not recruiting Study Name: Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell Lymphoma
Condition:
  • Adult B Acute Lymphoblastic Leukemia
  • Adult T Acute Lymphoblastic Leukemia
  • Drug: Alisertib Given PO
Completed Study Name: Ruxolitinib for the Treatment of T-Cell Large Granular Lymphocytic Leukemia
Condition: T-Cell Large Granular Lymphocyte Leukemia
Date: 2025-07-10
Interventions: Given PO
Completed Study Name: Siltuximab in Large Granular Lymphocytic Leukemia (LGLL)
Condition: Large Granular Lymphocyte Leukemia
Date: 2025-07-10
Interventions: Siltuximab will be given on day 1 of each cycle.The dose will be 11 mg/kg given over 1 hour by intravenous infusion.Each cycle is thr